登入選單
返回Google圖書搜尋
其他書名
Hypertension
出版CSF Medical Communications, 2003-03
ISBN19050640399781905064038
URLhttp://books.google.com.hk/books?id=TFT4AAAACAAJ&hl=&source=gbs_api
註釋Drugs in Context is an independent, peer reviewed and practice orientated review of all the significant data on a specific drug, placed in the context of the disease and clinical practice setting. Irbesartan Editorial: The recent World Health Organization statement identified hypertension as one of the most important, preventable causes of death worldwide. Disease Overview: The poor control of hypertension appears to be the result of poor detection and awareness of the condition, coupled with inadequate treatment. Drug Review: Irbesartan is a selective and potent AT1-receptor antagonist, which produces greater functional antagonism of AT II than other agents in its class. Improving Practice: Primary care still bears the responsibility for implementing best practice and must respond by developing new strategies to deliver enhanced, focused and appropriate care for our hypertensive patients.